Filter
635
Text search:
Serum
Institute
Featured
Recommendations
86
New Publications
181
Language
Document type
No document type
345
Guidelines
137
Studies & Reports
88
Manuals
21
Fact sheets
20
Strategic & Response Plan
14
Situation Updates
5
Training Material
3
Resource Platforms
2
Countries / Regions
India
96
Global
29
South Africa
17
Nigeria
14
Latin America and the Carribbean
13
Western and Central Europe
13
Ethiopia
12
Uganda
12
Kenya
12
Philippines
11
Germany
10
Bangladesh
8
Brazil
8
Nepal
7
Sierra Leone
6
Ghana
6
Zambia
6
Rwanda
6
Namibia
6
West and Central Africa
6
Indonesia
5
Eastern Europe
5
Liberia
4
Tanzania
4
East and Southern Africa
4
Africa
4
Congo, Democratic Republic of
3
USA
3
Pakistan
3
Syria
3
Myanmar / Burma
3
Venezuela
3
Guinea
2
Burkina Faso
2
South Sudan
2
Malawi
2
Mozambique
2
Sudan
2
Angola
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Paraguay
2
Russia
2
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Chad
1
Cambodia
1
North Macedonia
1
Switzerland
1
Colombia
1
Ecuador
1
Greece
1
Chile
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Bhutan
1
Poland
1
Albania
1
Moldova
1
Iran
1
Uzbekistan
1
Georgia
1
North America
1
Jamaica
1
Denmark
1
Tunisia
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
254
Clinical Guidelines
122
Public Health
38
Women & Child Health
26
Pharmacy & Technologies
20
Key Resources
7
Capacity Building
1
Toolboxes
COVID-19
72
Rapid Response
41
TB
40
NTDs
37
HIV
36
Mental Health
32
NCDs
32
Ebola
15
Pharmacy
14
Caregiver
13
Zika
12
AMR
12
Refugee
11
Planetary Health
9
Global Health Education
6
Specific Hazards
4
Disability
3
Cholera
3
Conflict
3
Polio
2
Natural Hazards
2
Health Financing Toolbox
1
Report of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
Mood disorders
Chapter E.2
This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence and additional information as they become available.
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o
...
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st
...
Emerging Infectious Diseases Vol. 16, No. 5, May 2010
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility testing of yeast
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec
...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Psychiatry and Pediatrics
Chapter I.4
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm
...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Neurology Asia 2006; 11 : 1 – 4
Review article